Tandem Diabetes Care (TNDM) Operating Margin Growth (5y) (2018 - 2026)
Tandem Diabetes Care (TNDM) Operating Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn |
| 10 | Tandem Diabetes Care | 1.15 Bn | 582.17 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -476.00 |
| Dec 31, 2025 | -825.00 |
| Sep 30, 2025 | -836.00 |
| Jun 30, 2025 | -1,051.00 |
| Mar 31, 2025 | -3,770.00 |
| Dec 31, 2024 | -218.00 |
| Sep 30, 2024 | -435.00 |
| Jun 30, 2024 | -1,187.00 |
| Mar 31, 2024 | -508.00 |
| Dec 31, 2023 | -1,855.00 |
| Sep 30, 2023 | 1,696.00 |
| Jun 30, 2023 | 2,121.00 |
| Mar 31, 2023 | -1,869.00 |
| Dec 31, 2022 | 1,572.00 |
| Sep 30, 2022 | 2,554.00 |
| Jun 30, 2022 | 8,283.00 |
| Mar 31, 2022 | 10,313.00 |
| Dec 31, 2021 | 5,223.00 |
| Sep 30, 2021 | 23,544.00 |
| Jun 30, 2021 | 7,735.00 |